These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25498086)

  • 21. Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?
    Bruminhent J; Thongprayoon C; Dierkhising RA; Kremers WK; Theel ES; Razonable RR
    Liver Transpl; 2015 Apr; 21(4):539-46. PubMed ID: 25597303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients.
    Bodro M; Sabé N; Lladó L; Baliellas C; Niubó J; Castellote J; Fabregat J; Rafecas A; Carratalà J
    Liver Transpl; 2012 Sep; 18(9):1093-9. PubMed ID: 22532316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does cytomegalovirus serology impact outcome after pediatric heart transplantation?
    Mahle WT; Fourshee MT; Naftel DM; Alejos JC; Caldwell RL; Uzark K; Berg A; Kanter KR;
    J Heart Lung Transplant; 2009 Dec; 28(12):1299-305. PubMed ID: 19783178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who among cytomegalovirus-seropositive liver transplant recipients is at risk for cytomegalovirus infection?
    Singh N; Wannstedt C; Keyes L; Wagener MM; Cacciarelli TV
    Liver Transpl; 2005 Jun; 11(6):700-4. PubMed ID: 15915496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surveillance cultures of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Boston Center for Liver Transplantation Cytomegalovirus Immune Globulin Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Werner BG; Griffith J
    Clin Infect Dis; 1997 May; 24(5):824-9. PubMed ID: 9142776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients.
    Varghese J; Subramanian S; Reddy MS; Shanmugam N; Balajee G; Srinivasan V; Venkataraman J; Mohamed R
    Indian J Med Res; 2017 Apr; 145(4):558-562. PubMed ID: 28862190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A hybrid strategy for the prevention of cytomegalovirus-related complications in pediatric liver transplantation recipients.
    Madan RP; Campbell AL; Shust GF; Kahn AR; Wistinghausen B; Posada R; Kerkar N; Shneider BL; Emre S; Herold BC
    Transplantation; 2009 May; 87(9):1318-24. PubMed ID: 19424031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
    Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
    Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk factors for cytomegalovirus syndrome and tissue-invasive cytomegalovirus disease in liver transplant recipients who have cytomegalovirus antigenemia.
    Kim JM; Kim SJ; Joh JW; Shin M; Moon JI; Jung GO; Choi GS; Kwon CH; Lee SK
    Transplant Proc; 2010 Apr; 42(3):890-4. PubMed ID: 20430198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children.
    Hussain T; Burch M; Fenton MJ; Whitmore PM; Rees P; Elliott M; Aurora P
    Circulation; 2007 Apr; 115(13):1798-805. PubMed ID: 17353448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus antigenemia and outcomes of patients undergoing allogeneic peripheral blood stem cell transplantation: effects of long-term high-dose acyclovir prophylaxis and preemptive ganciclovir treatment.
    Hazar V; Ugur A; Colak D; Saba R; Tezcan G; Kupesiz A; Karadogan I; Gultekin M; Yesilipek A; Undar L
    Jpn J Infect Dis; 2006 Aug; 59(4):216-21. PubMed ID: 16936338
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pre-transplant cytomegalovirus immunoglobulin G antibody levels could prevent severe cytomegalovirus infections post-transplant in liver transplant recipients: Experience from a tertiary care liver centre.
    Gupta E; Pamecha V; Verma Y; Kumar N; Rastogi A; Hasnian N; Bhadoria AS
    Indian J Med Microbiol; 2017; 35(4):499-503. PubMed ID: 29405140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human herpesvirus 6 in donor biopsies associated with the incidence of clinical cytomegalovirus disease and hepatitis C virus recurrence.
    Guardia AC; Stucchi RS; Sampaio AM; Milan A; Costa SC; Pavan CR; Boin Ide F
    Int J Infect Dis; 2012 Feb; 16(2):e124-9. PubMed ID: 22178541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus seroprevalence among solid organ donors in Hungary: correlations with age, gender, and blood group.
    Varga M; Görög D; Kári D; Környei E; Kis É; Túryné HJ; Jankovics I; Péter A; Toronyi É; Sárváry E; Fazakas J; Reusz G
    Transplant Proc; 2011 May; 43(4):1233-5. PubMed ID: 21620098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donated organ as a source of cytomegalovirus in orthotopic liver transplantation.
    Sutherland S; Bracken P; Wreghitt TG; O'Grady J; Calne RY; Williams R
    J Med Virol; 1992 Jul; 37(3):170-3. PubMed ID: 1331304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG
    Clin Infect Dis; 1996 Aug; 23(2):292-7. PubMed ID: 8842266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus infection and disease after liver transplantation. An overview.
    Stratta RJ; Shaeffer MS; Markin RS; Wood RP; Langnas AN; Reed EC; Donovan JP; Woods GL; Bradshaw KA; Pillen TJ
    Dig Dis Sci; 1992 May; 37(5):673-88. PubMed ID: 1314159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytomegalovirus Infection After Intestinal/Multivisceral Transplantation: A Single-Center Experience With 210 Cases.
    Nagai S; Mangus RS; Anderson E; Ekser B; Kubal CA; Fridell JA; Tector AJ
    Transplantation; 2016 Feb; 100(2):451-60. PubMed ID: 26247555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.